FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 43% Somewhat Weak
Profitability n.A. n.A.
Fin. Growth 33% Weak
Leverage & Liquidity 17% Weak
Per Share Metrics 33% Weak
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q4 Q1 Δ in %
EV/EBITDA -39.88 7.25 12.06
Graham Fair Price 27.18 82164.52 64605.83
PEG -55.27 -0.02 0.04
Price/Book -5.20 0.39 0.42
Price/Cash Flow -49.46 -7.90 15.62
Prices/Earnings -36.35 4.25 -6.67
Price/Sales 8.19 0.38 0.35
Price/FCF -49.46 -7.90 15.62
Naive Interpretation member
01 - Valuation · Somewhat Weak
Fundamentals

Profitability

Metric Q4 Q1 Δ in %
Gross Profit Margin 21.24 0.26 0.21
Operating Margin 367.10 0.06 0.01
ROA 52.37 < 0.005 < 0.005
ROE -0.02 0.02 48.95
ROIC < 0.005 0.03 259.07
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q4 Q1 Δ in %
Debt QOQ 0.02 < 0.005 79.88
Dividends QOQ 1168.00 -1.00 -99.91
EBIT QOQ -0.69 3.26 376.05
EPS QOQ -1.79 2.55 42.30
FCF QOQ -0.06 -2.95 -4911.58
Revenue QOQ 0.12 -0.09 -24.83
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q4 Q1 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 45.03 57.50 27.69
Days Sales Outstanding (DSO) 43.69 52.62 20.44
Inventory Turnover 2.00 1.57 -21.69
Debt/Capitalization 0.41 0.40 -1.36
Quick Ratio 0.82 0.81 -1.31
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q4 Q1 Δ in %
Book Value 109208.63 113801.78 4.21
Cash 47697.52 39698.04 -16.77
Capex -5628.78 -5228.89 7.10
Free Cash Flow 2902.80 -5673.48 95.45
Revenue 128309.09 117156.53 -8.69
Naive Interpretation member
05 - Per Share Metrics · Weak
Fundamentals

Financial Health

Metric Q4 Q1 Δ in %
Current Ratio 1.26 1.29 2.73
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 5.12 3.55 -30.65
Naive Interpretation Member
06 - Financial Health · Weak
Rating